2,741 results on '"Gladman, Dafna D"'
Search Results
102. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
103. Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
104. Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation
105. Evolving concepts in systemic lupus erythematosus damage assessment
106. A Conditional Markov Model for Clustered Progressive Multistate Processes under Incomplete Observation
107. Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations
108. Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience
109. Correspondence on “relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus” by Chi Chiu Mok et al
110. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
111. Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study
112. Tracing Studies and Analysis of the Effect of Loss to Follow-up on Mortality Estimation from Patient Registry Data
113. Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research
114. Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis
115. Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis
116. Proceedings of the GRAPPA 2022 Executive Retreat.
117. Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting.
118. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
119. Persistence of Biologics in the Treatment of Psoriatic Arthritis (Psa): Data From a Large Hospital Based Longitudinal Cohort
120. Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
121. Cardiac Magnetic Resonance Imaging T1 and T2 Mapping in Systemic Lupus Erythematosus in Relation to Antimalarial Treatment
122. Addressing comorbidities in psoriatic disease
123. Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics (SLICC) Cohort using Multistate Modelling
124. Genetics of osteonecrosis in children and adults with systemic lupus erythematosus
125. Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network
126. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
127. Association of variably expressed KIR3dl1 alleles with psoriatic disease
128. Author Correction: Evolving concepts in systemic lupus erythematosus damage assessment
129. sj-docx-1-tab-10.1177_1759720X221149965 – Supplemental material for Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
130. Spondyloarthritis: Psoriatic Arthritis
131. Persistence of Biologics in the Treatment of Psoriatic Arthritis: Data From a Large Hospital‐BasedLongitudinal Cohort
132. Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis
133. Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients
134. Evaluating the Construct of Damage in Systemic Lupus Erythematosus
135. Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network
136. Improving measures of disease activity in systemic lupus erythematosus
137. 1117 Neutrophil extracellular traps as a biomarker to predict outcomes in lupus nephritis
138. 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort
139. The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes
140. 603 Remission and low disease activity are associated with lower health care costs in an international inception cohort of patients with systemic lupus erythematosus
141. Musculoskeletal Surgery in Psoriatic Arthritis: Prevalence and Risk Factors
142. Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
143. Evaluating the Threshold Score for Classification of Systemic Lupus Erythematosus Using the EULAR/ACR Criteria
144. Sex Effect in Psoriatic Arthritis
145. Isolated Neutropenia in Systemic Lupus Erythematosus
146. Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics
147. Psoriasis in systemic lupus erythematosus: a single-center experience
148. Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis
149. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
150. Outcomes following antimalarial withdrawal in patients with quiescent systemic lupus erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.